Craft

Valeo Pharma

Stock Price

$0.5

2022-05-27

Market Capitalization

$52 M

2022-05-27

Revenue

$53.9 M

FY, 2023

Valeo Pharma Summary

Company Summary

Overview
Valeo Pharma is a pharmaceutical company that provides healthcare professionals and patients with specialty products and healthcare solutions. It offers a range of medications focusing on neurodegenerative diseases, women’s health, oncology, and other therapeutic areas. The company operates in two business sectors: branded prescription products and hospital injectable products.
Type
Public
Status
Active
Founded
2003
HQ
Kirkland, CA | view all locations
Website
https://www.valeopharma.com
Cybersecurity rating
Sectors

Key People

  • Richard J. MacKay, Chairman

    • Steve Saviuk

      Steve Saviuk, Chief Executive Officer, Director

      • Luc Mainville

        Luc Mainville, Senior Vice-President, Chief Financial Officer

      LocationsView all

      1 location detected

      • Kirkland, QC HQ

        Canada

        16667 Boul Hymus

      Valeo Pharma Financials

      Summary Financials

      Revenue (Q3, 2024)
      $C12.6M
      Gross profit (Q3, 2024)
      $C1.3M
      Net income (Q3, 2024)
      ($C8.2M)
      Cash (Q3, 2024)
      $C7.1M
      EBIT (Q3, 2024)
      ($C2.8M)
      Enterprise value
      $115.0M

      Footer menu